VasQ and A

The FDA has approved VasQ, a new device to reduce fistula failure, for a 2-year clinical trial with 129 patients. The device keeps fistulas from growing too large by providing an external support.

Read the full article » | Posted 08-17-2017

Related Articles

• AWAK is now Singapore-based Vivance Posted 05-20-2025
• Archimedes by Simergent Promises Quieter, Less Painful APD Posted 05-20-2025
• PeritoneX by Relavo Medical Posted 05-20-2025
• Wearable PD Device to Purify and Reuse Dialysate Posted 04-23-2025